2021 Biotherapy Industry Conference

2021 Biotherapy Industry Conference

World Congress of Biotherapy Industry-2021

(WCBI -20 21)

June 19-20, 2021 Shanghai, China

Investment invitation letter

Organizer: Four-leaf Clover Exhibition, Biological Products Circle

Supporting unit: Lu Daopei Medical Group

1.

1.

2.

3.
Location: Shanghai, China

4.
Scale: 50+ speakers, 600+ participants

2.
Conference background

Biological therapy has achieved rapid development in the past 30 years and is currently the most eye-catching and inspiring focus in the field of biomedicine, and has become an indispensable and important part of clinical treatment.
In the field of cell therapy, autoimmune cell therapy technologies (CAR-T, TCR-T, CTL, TIL and DC) have made major breakthroughs.
At present, 3 CAR-T cell therapies have been approved for marketing worldwide; Biotherapeutics represented by therapeutic antibodies, vaccines and proteins have been widely used in various disease treatment fields.

3.
Introduction to the conference

In order to promote the basic research of my country's biotherapy, the industrialization of new technologies and clinical applications, we will build a communication platform for researchers, R&D companies and clinicians, analyze research hotspots and policy standards at home and abroad, and discuss global market trends and business development Direction, the 2021 Biotherapy Industry Conference will be held in Shanghai from June 19-20.

The organizing committee will invite academicians, authoritative experts, well-known scholars, clinicians, and industry-leading corporate executives in the field of biotherapy at home and abroad to attend the grand event to disseminate the latest research information and showcase the latest products and technologies.
The main contents of the conference are: immune cell therapy, stem cell therapy, gene therapy, oncolytic virus drug development, RNA drug research and development, bispecific antibody research and development, antibody conjugate drug (ADC) research and development, cell product process development, and biological drug production process Six forums including quality control and quality control will discuss more than one hundred topics.
The main forms of the conference include opening ceremony, keynote speech, entrepreneur summit, high-end dialogue, special forum, media interview, corporate exhibition, project roadshow, corporate satellite conference, etc.
This conference was hosted by Clover Exhibition and received strong support from Lu Daopei Medical Group, professional media in the bioproducts circle and industry associations.

On behalf of the organizing committee, I sincerely invite your company to participate in this summit, through the summit platform, to shape the brand, promote the enterprise, display products, and expand the market.

6.

On March 23, 2019, the Biotherapeutic Industry Conference with the theme of "Exploring the future development of the biotherapeutic industry and leading breakthroughs in advanced therapeutic technology innovation" was grandly opened in Beijing.

At the conference theme forum, Fan Daiming, Academician of Chinese Academy of Engineering, Dean of Xijing Digestive Disease Hospital of Air Force Military Medical University, and Chairman of Chinese Anti-Cancer Association, gave a report on "Reverse Research of Medicine"; from the Biotherapy Center of Sun Yat-sen University Affiliated Tumor Hospital Director Xia Jianchuan gave a report on the "Problems and Countermeasures of Targeted Malignant Solid Tumor Immune Cell Therapy"; Li Zhong, Vice President of Shanghai Institute of Cell Therapy, gave a report on "Precisely targeted tumor local immunotherapy may become a cure for tumors.

Application" report.

In the "Entrepreneur Summit Forum" held subsequently, Mr.
Zhou Xinhua, CEO of Jiahe Biotech, Mr.
Zhou Pengfei, founder and CEO of Youzhiyou Biopharmaceutical Company, Ms.
Jin Ge, founder and CEO of Rendong Medical, and Jianshun

The six entrepreneurs, Mr.
Luo Shun, founder and president of Biology, Mr.
Bai Yuezong, senior strategic marketing director of Siddi Precision Medical Group, and Ms.
Fan Jing, general manager and co-founder of Hod Biotech, published their own opinions on the "Future Trends of Biological Therapy".
Views, and published future trends and market analysis, corporate development strategies, etc.
from antibody research and development, tumor precision detection, cell culture technology, stem cell therapy, etc.
, and the discussions were very lively.

In the group forums of the next two days, more than 60 speakers discussed tumor immunotherapy, genetic testing, biomedical big data, precision medicine, personalized therapy, in vitro diagnostics, antibody development, stem cell therapy, emerging vaccine development, gene therapy, Delivered speeches on cutting-edge technologies and clinical progress such as gene editing technology.

Seven, contact information

Participation registration: Conference fee: Provide participation benefits for biomedical technology R&D personnel, report before May 20

Name FREE! (Only a deposit of 100 yuan will be charged, including coffee breaks, conference materials, etc.

Registration: scanning the bottom two-dimensional code or click on the very bottom of the article, " read the original " fill in the form → → successful registration!

If you need sponsorship, just scan the QR code to register!

After obtaining the registration information, the organizing committee will conduct a preliminary screening based on the registration information , and further communicate and confirm with the applicants to achieve precise invitations.

Exhibitor Contact: Manager Xu Tel/WeChat: 18647676947 Email: nancy@flcevent.